LAUNCHES, PROMOTIONS, MERCHANDISING, EVENTS AND OTHER THINGS TO KEEP YOU IN THE KNOW.
COOPERVISION REPORT: ECPs MISSING DIGITAL OPPORTUNITY
Nearly four out of five contact lens wearers would like to explore ways to reduce digital eye fatigue with an eyecare practitioner, and nearly three out of four are willing to pay a premium for a contact lens that accomplishes this, according to the latest Digital Device Usage and Your Eyes report from CooperVision, Inc. YouGov.com conducted a multifaceted survey among 9,343 adults, including 1,282 contact lens wearers, in the U.S., Australia, France, Germany, Spain and the United Kingdom. Results showed that:
- Some 19% of individuals who use vision correction and 18% of individuals who do not are concerned about the amount of time spent looking at screens. This edges higher—to 26%—for contact lens wearers.
- Just 14% of contact lens wearers said that they had spoken with an ECP about digital device use, yet 78% said they would be very or somewhat interested in exploring ways to reduce eye tiredness with their ECPs.
- Nearly one in three contact lens wearers responding to a follow-up survey would be willing to pay a premium for an option that reduces symptoms of digital eye fatigue.
To download the report, go to CooperVision.com/Digital-Report.
ABB OPTICAL RELEASES PRACTICE EFFICIENCY REPORT
“Access and choice” and “one- to two-day shipping” are the two most important considerations ECPs have when ordering soft contact lenses, according to ABB OPTICAL GROUP’s fall 2017 practice efficiency survey. Other important considerations include online ordering, direct-to-patient shipping and providing one bill. The survey also revealed that practices spend an average of 70 minutes managing soft contact lenses and that ODs underestimate the effort by 20%. Also, more than 90% of practices agree that consolidating orders through a distributor makes their practices run more efficiently. To learn more, contact Angela Moore at ABB OPTICAL GROUP, AMoore@ABBOptical.com or 954.733.2300 x 7614.
EYEFNITY PROGRAM CERTIFIES STUDENTS IN EHR USAGE
Eyefinity launched its Student Certification Program, which provides optometry students nationwide an opportunity to learn Eyefinity EHR and become a certified user. Topics include the ins and outs of documenting exams in the largest PM platform in private-practice optometry and HR integrations for government regulations. Students can earn a badge as an Eyefinity EHR Certified User to share on social media pages, including LinkedIn. The next Go Live sessions are scheduled for June 14 and August 31. Call 800.269.3666, or go to Eyefinity.com.
STUDIES CITE BENEFITS OF LIPIFLOW FOR MGD
Two studies in Clinical Ophthalmo-logy demonstrated clinical benefits of Johnson & Johnson Vision’s LipiFlow treatment for meibomian gland dysfunction (MGD). LipiFlow and LipiFlow II (pictured, below) were introduced by Tear Science, which J&J acquired last year. In the first study, a single LipiFlow treatment significantly improved mean meibomian gland function and significantly reduced mean dry eye signs and symptoms from baseline to three months for soft contact lens wearers with MGD compared to those in an untreated control arm. LipiFlow treatment also increased comfortable contact lens wearing time by approximately four hours per day, on average. In the second study, one 12-minute treatment with LipiFlow was significantly more effective at improving dry eye symptoms associated with MGD than three months of oral doxycycline taken daily. Go to TearScience.wpengine.com/LipiFlow/.
TANGIBLE SCIENCE LAUNCHES DISPOSABLE CONTACT LENSES
Tangible Science, LLC has expanded its product family to include disposable contact lenses that are FDA-approved and that use the polymer-based science behind its Tangible Hydra-PEG coating in custom contact lenses. The company’s disposable lenses incorporate a reformulation of proprietary Tangible polymer into the lens material and in the lens packaging. Its first offering will be a daily disposable hydrogel lens sold and distributed by SynergEyes. Call 650.241.1045, or go to TangibleScience.com.
CENTER DISTANCE FLEXOPTICS EXPANDD SYNERGEYES’ DUETTE PROGRESSIVE LINE
SynergEyes, Inc. has expanded its Duette Progressive hybrid line with the addition of a new lens featuring Center Distance FlexOptics, with an adjustable center distance zone size ranging from 1.8mm to 4.0mm and driven by photopic pupil size. Available add powers are +0.75D to +5.00D. The Duette Progressive line now offers hybrid lenses customizable for the continuum of presbyopia, even for patients who have astigmatism. Call 877.733.2012, or go to SynergEyes.com.
Imprimis Pharmaceuticals, Inc. now dispenses preservative-free dorzolamide and a preservative-free dorzolamide/timolol formulation, a move the company began after dorzolamide and the commercial products, Cosopt and Cosopt PF, were added to the FDA Drug Shortage List.
EyePromise and its parent company, ZeaVision Holdings, LLC, named chairman and CEO Dennis Gierhart, PhD., as its interim-president and promoted Bob Kearns to senior vice president of sales, Brad Hogenmiller to vice president, technology & marketing, and Patrick Curran to senior director of sales.
The Neuro-Optometric Rehabilitation Association, International has named Gary Esterow, who founded and operates Esterow Communications, as its executive director.
TearLab has passed the acceptance review phase with the FDA for the clearance of its TearLab Discovery Platform, the company’s next-generation in-vitro diagnostic testing system, and hopes to bring it to market in the second half of this year.
OCuSOFT Inc. announced that it has formed OCuSOFT U.K. Ltd. from which it will offer OCuSOFT Lid Scrub Original and OCuSOFT Lid Scrub PLUS products in this region.
VSP Global appointed Michael J. Guyette president and CEO to succeed VSP Global board member Rob Lynch, interim president and CEO since April 2017.
The University of the Incarnate Word, Rosenberg School of Optometry has launched the Fellowship in Ocular Disease and Optometric Surgery in rural Logansport, LA, to provide optometrists with advanced clinical training.